Pharmaceutical Technology-04-02-2012

Pharmaceutical Technology

Pharmaceutical Technology, April 2012 Issue (PDF)

April 02, 2012

Issue PDF

36

4

Navigating the Equipment and Machinery Market

Evaluating Impurities in Drugs (Part III of III)

April 02, 2012

Peer-Reviewed Research

36

4

In Part III of a three-part article, the authors examine various degradation routes of APIs, impurities arising from interactions in formulations, metabolite impurities, various analytical methods to measure impuritie, and ways to control impurities.

A Sustainable Biotech Path

April 02, 2012

BioForum

36

4

With financing constrained, biotechnology firms must find ways to sustain innovation.

Product Quality Lifecycle Implementation

April 02, 2012

Special Features

36

4

The authors provide an overview of the new ISPE Guide Series on Product Quality Lifecycle Implementation and how the guides can be used in a complementary way with existing guidance from FDA and the International Conference on Harmonization.

Regulation and Compliance: Deviation Investigations

April 02, 2012

In the Field

36

4

Q&A with Peter Smith and David Elder, Strategic Compliance Consulting, PAREXEL International, on acceptable deviation investigations. Smith and Elder are both former senior officials with FDA.